Effectiveness of the polysaccharide pneumococcal vaccine among HIV-infected persons in Brazil: a case control study
2007

Effectiveness of Pneumococcal Vaccine in HIV-Infected Adults in Brazil

Sample size: 321 publication Evidence: low

Author Information

Author(s): Maria Amelia SM Veras, Wayne TA Enanoria, Euclides A Castilho, Arthur L Reingold

Primary Institution: University of California, Berkeley

Hypothesis

What is the effectiveness of the 23-valent polysaccharide pneumococcal vaccine against invasive pneumococcal infection among HIV-infected adults in Brazil?

Conclusion

The study found no statistically significant protective effect of the pneumococcal vaccine against invasive pneumococcal infection among HIV-infected adults in Brazil.

Supporting Evidence

  • The vaccine effectiveness was estimated at 18%, which is low.
  • The study included a total of 321 participants, with 79 cases and 242 controls.

Takeaway

The pneumococcal vaccine might not help people with HIV in Brazil as much as we hoped.

Methodology

A case-control study with 79 cases and 242 controls matched on CD4+ cell count and health care setting.

Potential Biases

Potential biases may arise from the observational nature of the study and matching criteria.

Limitations

The study could not include all patients with invasive pneumococcal disease due to various reasons, including consent issues.

Participant Demographics

HIV-infected adults over 18 years old in São Paulo, Brazil.

Statistical Information

Confidence Interval

95% CI: <0 to 62%

Digital Object Identifier (DOI)

10.1186/1471-2334-7-119

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication